Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation

被引:513
作者
Waelter, S [1 ]
Boeddrich, A [1 ]
Lurz, R [1 ]
Scherzinger, E [1 ]
Lueder, G [1 ]
Lehrach, H [1 ]
Wanker, EE [1 ]
机构
[1] Max Planck Inst Mol Genet, D-14195 Berlin, Dahlem, Germany
关键词
D O I
10.1091/mbc.12.5.1393
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The huntingtin exon 1 proteins with a polyglutamine repeat in the pathological range (51 or 83 glutamines), but not with a polyglutamine tract in the normal range (20 glutamines), form aggresome-like perinuclear inclusions in human 293 Tet-Off cells. These structures contain aggregated, ubiquitinated huntingtin exon 1 protein with a characteristic fibrillar morphology. Inclusion bodies with truncated huntingtin protein are formed at centrosomes and are surrounded by vimentin filaments. Inhibition of proteasome activity resulted in a twofold increase in the amount of ubiquitinated, SDS-resistant aggregates, indicating that inclusion bodies accumulate when the capacity of the ubiquitin-proteasome system to degrade aggregation-prone huntingtin protein is exhausted. Immunofluorescence and electron microscopy with immunogold labeling revealed that the 20S, 19S, and 11S subunits of the 26S proteasome, the molecular chaperones BiP/GRP78, Hsp70, and Hsp40, as well as the RNA-binding protein TIA-1, the potential chaperone 14-3-3, and alpha -synuclein colocalize with the perinuclear inclusions. In 293 Tet-Off cells, inclusion body formation also resulted in cell toxicity and dramatic ultrastructural changes such as indentations and disruption of the nuclear envelope. Concentration of mitochondria. around the inclusions and cytoplasmic vacuolation were also observed. Together these findings support the hypothesis that the ATP-dependent ubiquitin-proteasome system is a potential target for therapeutic interventions in glutamine repeat disorders.
引用
收藏
页码:1393 / 1407
页数:15
相关论文
共 57 条
  • [1] 14-3-3 and its possible role in co-ordinating multiple signalling pathways
    Aitken, A
    [J]. TRENDS IN CELL BIOLOGY, 1996, 6 (09) : 341 - 347
  • [2] [Anonymous], [No title captured]
  • [3] [Anonymous], 1991, HUNTINGTONS DIS
  • [4] Energetics in the pathogenesis of neurodegenerative diseases
    Beal, MF
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (07) : 298 - 304
  • [5] Ubiquitin and the control of protein fate in the secretory and endocytic pathways
    Bonifacino, JS
    Weissman, AM
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 : 19 - 57
  • [6] Evidence for proteasome involvement in polyglutamine disease:: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
    Chai, YH
    Koppenhafer, SL
    Shoesmith, SJ
    Perez, MK
    Paulson, HL
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (04) : 673 - 682
  • [7] Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models
    Charles, V
    Mezey, E
    Reddy, PH
    Dehejia, A
    Young, TA
    Polymeropoulos, MH
    Brownstein, MJ
    Tagle, DA
    [J]. NEUROSCIENCE LETTERS, 2000, 289 (01) : 29 - 32
  • [8] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [9] Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture
    Cooper, JK
    Schilling, G
    Peters, MF
    Herring, WJ
    Sharp, AH
    Kaminsky, Z
    Masone, J
    Khan, FA
    Delanoy, M
    Borchelt, DR
    Dawson, VL
    Dawson, TM
    Ross, CA
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (05) : 783 - 790
  • [10] Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
    Cummings, CJ
    Mancini, MA
    Antalffy, B
    DeFranco, DB
    Orr, HT
    Zoghbi, HY
    [J]. NATURE GENETICS, 1998, 19 (02) : 148 - 154